CytoDyn (CYDY) Enterprise Value Growth (3y) (2013 - 2026)
CytoDyn (CYDY) Enterprise Value Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CytoDyn | 267.79 Mn | 267.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -45.22% |
| Nov 30, 2025 | -192.05% |
| Aug 31, 2025 | -25.90% |
| May 31, 2025 | -41.17% |
| Feb 28, 2025 | -154.07% |
| Nov 30, 2024 | -33.96% |
| Aug 31, 2024 | -56.25% |
| May 31, 2024 | 41.76% |
| Feb 29, 2024 | 53.86% |
| Nov 30, 2023 | 82.90% |
| Aug 31, 2023 | -531.19% |
| May 31, 2023 | 43.77% |
| Feb 28, 2023 | 10.19% |
| Nov 30, 2022 | 21.25% |
| Aug 31, 2022 | -37.57% |
| May 31, 2022 | -6.87% |
| Feb 28, 2022 | 14.39% |
| Nov 30, 2021 | -125.66% |
| Aug 31, 2021 | -11.21% |
| May 31, 2021 | -202.07% |